TYRA vs UNCY

Tyra Biosciences, Inc. vs Unicycive Therapeutics, Inc. — Valuation Comparison 2026

TYRA

Biotechnology
Tyra Biosciences, Inc.
Quality
4.3
out of 10
Value Trap
18
SAFE
Price
$32.68
Last close
Models
7/13
Active
VS

UNCY

Biotechnology
Unicycive Therapeutics, Inc.
Quality
4.3
out of 10
Value Trap
36
LOW
Price
$7.02
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType TYRA Fair ValueTYRA Upside UNCY Fair ValueUNCY Upside
Bayesian DCF Intrinsic $9.52 -70.9% $2.65 -62.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $0.56 -92.7%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $5.32 -83.7% $1.54 -78.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TYRA vs UNCY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TYRA vs UNCY — Which Stock Is More Undervalued?

TYRA scores higher with a 4.3/10 quality rating vs UNCY's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tyra Biosciences, Inc. (TYRA) and Unicycive Therapeutics, Inc. (UNCY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TYRA currently trades at $32.68 with a QOC of 4.3/10, while UNCY trades at $7.02 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).